Glioblastoma in the elderly — How do we choose who to treat?

This publication has 10 references indexed in Scilit:

• International Atomic Energy Agency Randomized Phase III Study of Radiation Therapy in Elderly and/or Frail Patients With Newly Diagnosed Glioblastoma Multiforme
  Journal of Clinical Oncology, 2015
• Glioblastoma in England: 2007–2011
  European Journal of Cancer, 2015
• Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations
  Annals of Oncology, 2015
• Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial
  The Lancet Oncology, 2012
• Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial
  The Lancet Oncology, 2012
• Early measures of cognitive function predict survival in patients with newly diagnosed glioblastoma
  Neuro-Oncology, 2012
• Predicting Chemotherapy Toxicity in Older Adults With Cancer: A Prospective Multicenter Study
  Journal of Clinical Oncology, 2011
• Radiotherapy for Glioblastoma in the Elderly
  New England Journal of Medicine, 2007
• Glioblastoma—the consequences of advanced patient age on treatment and survival
  Neurosurgical Review, 2006
• Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
  New England Journal of Medicine, 2005